Top

Annals of Surgical Oncology

Published in:

01-01-2007

Predictors for Patterns of Failure after Pancreaticoduodenectomy in Ampullary Cancer

Authors: Hui-Ping Hsu, MD, Ta-Ming Yang, MD, Yu-Hsiang Hsieh, PhD, Yan-Shen Shan, MD, PhD, Pin-Wen Lin, MD

Published in: Annals of Surgical Oncology | Issue 1/2007

Abstract

Background

Ampullary cancer has the best prognosis in periampullary malignancy but unpredicted early recurrence after resection is frequent. The current study tried to find the predictors for recurrence to be used as determinative for postoperative adjuvant therapy.

Methods

Information was collected from patients who underwent pancreaticoduodenectomy with regional lymphadenectomy for ampullary cancer in high-volume hospitals between January 1989 and April 2005. Recurrence patterns and survival rates were calculated and predictors were identified.

Results

A total of 135 eligible patients were included. The 30-day operative mortality was 3%. Median followup for relapse-free patients was 52 months. Disease recurred in 57 (42%) patients, including 31 liver metastases, 26 locoregional recurrences, 9 peritoneal carcinomatoses, 7 bone metastases, and 6 other sites. Pancreatic invasion (P = 0.04) and tumor size (P = 0.05) were the predictors for locoregional recurrence, while lymph node metastasis was the sole predictor for liver metastasis (P = 0.01). The 5-year disease-specific survival rate was 45.7%; 77.7% for stage I, 28.5% for stage II, and 16.5% for stage III; and 63.7% for node-negative versus 19.1% for node-positive patients. Pancreatic invasion and lymph node involvement were both predictors for survival of patients with ampullary cancer.

Conclusion

Pancreaticoduodenectomy with regional lymphadenectomy is adequate for early-stage ampullary cancer but a dismal outcome can be predicted in patients with lymph node metastasis and pancreatic invasion. Lymph node metastasis and pancreatic invasion can be used to guide individualized, risk-oriented adjuvant therapy.

Yamaguchi K, Enjoji M. Carcinoma of the ampulla of Vater: a clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma. Cancer 1987; 59:506-515PubMedCrossRef

Nakase A, Matsumoto Y, Uchida K, et al. Surgical treatment of cancer of the pancreas and the periampullary region: cumulative results in 57 institutions in Japan. Ann Surg 1977; 185(1):52-57PubMedCrossRef

Warren KW, Choe DS, Plaza J, et al. Results of radical resection for periampullary cancer. Ann Surg 1975; 181(5):534-540PubMedCrossRef

Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampulla of Vater: a 28-year experience. Ann Surg 1997; 225(5):590-600PubMedCrossRef

Yoon YS, Kim SW, Park SJ, et al. Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy. Ann Surg 2005; 242(1):92-100PubMedCrossRef

Böttger TC, Boddin J, Heintz A, et al. Clinicopathologic study for the assessment of resection for ampullary carcinoma. World J Surg 1997; 21:379-383PubMedCrossRef

Roder JD, Schneider PM, Stein HJ, et al. Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg 1995; 82:1693-1696PubMedCrossRef

Bakkevold KE, Arnesjø B, Dahl O, et al. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater- results of a controlled, prospective randomized multicentre study. Eur J Cancer 1993; 29A(5):698-703PubMedCrossRef

Sikora SS, Balachandran P, Dimri K, et al. Adjuvant chemo-radiotherapy in ampullary cancers. Eur J Surg Oncol 2005; 31: 158–163PubMedCrossRef

10.

Lin PW, Lee JC, Lee PC, Chang TW, Hung CJ, Chang YC. A simple, secure and universal pancreaticojejunostomy following pancreaticoduodenectomy. HPB Surg 1997; 10:305-310PubMedCrossRef

11.

Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 1999; 86:603-607PubMedCrossRef

12.

Shan YS, Sy ED, Lin PW. Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trail. World J Surg 2003; 27:709-714PubMedCrossRef

13.

Shan YS, Hsieh YH, Sy ED, Lin PW. Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy. J Formos Med Assoc 2004; 103:767-772PubMed

14.

Greene FL, Page DL, Fleming ID, et al. (2002). AJCC Cancer Staging Manual, 6th ed. New York: Springer, pp 151–153

15.

Todoroki T, Koike N, Morishita Y, et al. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 2003; 10(10):1176-1183PubMedCrossRef

16.

Lee JH, Whittington R, Williams NN, et al. Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys 2000; 47(4):945-953PubMedCrossRef

17.

Delcore R, Connor CS, Thomas JH, et al. Significance of tumor spread in adenocarcinoma of the ampulla of Vater. Am J Surg 1989; 158:593-597PubMedCrossRef

18.

Beger HG, Treitschke F, Gansauge F, et al. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg 1999; 134:526-532PubMedCrossRef

19.

Monson JR, Donohue JH, McEntee GP, et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg 1991; 126:353-357PubMed

20.

Shirai Y, Tsukada K, Ohtani T, et al. Carcinoma of the ampulla of Vater: is radical lymphadenectomy beneficial to patients with nodal disease? J Surg Oncol 1996; 61:190-194PubMedCrossRef

21.

Matory YL, Gaynor J, Brennan M. Carcinoma of the ampulla of Vater. Surg Gynecol Obstet 1993; 177:366-370PubMed

22.

Allema JH, Reinders ME, van Gulik TM, et al. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival. Surgery 1995; 117:247-253PubMedCrossRef

23.

Yeo CJ, Sohn TA, Cameron JL, et al. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 1998; 227(6):821-831PubMedCrossRef

24.

Akwari OE, van Heerden JA, Adson MA, et al. Radical pancreatoduodenectomy for cancer of the papilla of Vater. Arch Surg 1977; 112:451-456PubMed

25.

Williams JA, Cubilla A, Maclean BJ, et al. Twenty-two year experience with periampullary carcinoma at Memorial Sloan-Kettering Cancer Center. Am J Surg 1979; 138:662-665PubMedCrossRef

26.

Kayahara M, Nagakawa T, Ohta T, et al. Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery 1997; 121:611-617PubMedCrossRef

27.

Howe JR, Klimstra DS, Moccia RD, et al. Factors predictive of survival in ampullary carcinoma. Ann Surg 1998; 228(1):87-94PubMedCrossRef

28.

Schmidt CM, Powell ES, Yiannoutsos CT, et al. Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 2004; 139:718-727PubMedCrossRef

29.

Brown KM, Tompkins AJ, Yong S, et al. Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg 2005; 140:529-533PubMedCrossRef

30.

Nakano K, Chijiiwa K, Toyonaga T, et al. Combination therapy of resection and intraoperative radiation for patients with carcinomas of extrahepatic bile duct and ampulla of Vater: prognostic advantage over resection alone? Hepatogastroenterology 2003; 50:928-933PubMed

31.

Willett CG, Warshaw AL, Convery K, et al. Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma. Surg Gynecol Obstet 1993; 176:33-38PubMed

32.

Mehta VK, Fisher GA, Ford JM, et al. Adjuvant chemoradiotherapy for “unfavorable” carcinoma of the ampulla of Vater: preliminary report. Arch Surg 2001; 136:65-69PubMedCrossRef

Title: Predictors for Patterns of Failure after Pancreaticoduodenectomy in Ampullary Cancer
Authors: Hui-Ping Hsu, MD
Ta-Ming Yang, MD
Yu-Hsiang Hsieh, PhD
Yan-Shen Shan, MD, PhD
Pin-Wen Lin, MD
Publication date: 01-01-2007
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 1/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-006-9136-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Predictors for Patterns of Failure after Pancreaticoduodenectomy in Ampullary Cancer

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2007

Characteristics and Treatment of Metaplastic Breast Cancer: Analysis of 892 Cases from the National Cancer Data Base

Risk Factors for Non-Sentinel Lymph Node Metastases in Patients with Breast Cancer. The Outcome of a Multi-institutional Study

Early Postoperative Intraperitoneal Chemotherapy Following Cytoreductive Surgery in Patients with Very Advanced Gastric Cancer

Complications after Extended (D2) and Superextended (D3) Lymphadenectomy for Gastric Cancer: Analysis of Potential Risk Factors

Oncologic Results of Laparoscopic Versus Conventional Open Surgery for Stage II or III Left-Sided Colon Cancers: A Randomized Controlled Trial

Hematoma-Directed Ultrasound-Guided (HUG) Breast Lumpectomy